Adrenal crisis mainly manifested as recurrent syncope secondary to tislelizumab: a case report and literature review

We report this case to improve our understanding of this situation, identify this kind of disease, and prevent adrenal crisis in time. Eventually, limiting toxicities reduces the interruption of immunotherapy. Since irAEs are multisystem damage with more non-specific symptoms, except for oncologists, general practitioners who endorse the need for taking a holistic approach to the patient should play a vital role in the management of cancer treatment.
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research